天臣医疗(688013.SH)：预计2025年净利润同比增加59.74%到71.30%

Core Viewpoint - Tianchen Medical (688013.SH) expects a significant increase in net profit for the year 2025, projecting a rise of 31 million to 37 million yuan, which translates to a year-on-year increase of 59.74% to 71.30% [1] Financial Performance - The company anticipates that the net profit attributable to the parent company, excluding non-recurring gains and losses, will increase by 27 million to 31 million yuan, reflecting a year-on-year growth of 57.77% to 66.32% [1] Strategic Initiatives - The company continues to adhere to an innovation-driven strategy, enhancing both domestic and international operations, and consistently providing a rich product matrix to customers [1] Product Sales - Sales revenue from the company's endoscopic stapler products has shown stable growth during the reporting period [1] Currency Impact - The company experienced an increase in foreign exchange gains due to currency fluctuations affecting its foreign currency monetary items [1]